Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women

Sponsor
National Institute of Medical Sciences and Nutrition, Salvador Zubiran (Other)
Overall Status
Withdrawn
CT.gov ID
NCT01829009
Collaborator
(none)
0
1
2

Study Details

Study Description

Brief Summary

Aging is characterized by a progressive loss of multiple physical and cognitive abilities. From these changes, the most important one is the loss of muscle mass, which has been called "sarcopenia". Resistance exercise is a therapeutic approach for sarcopenia, nevertheless there is no universal consensus. Therefore, this research is interested in determining the effect of a resistance exercise program on physical performance and/or functional status in sarcopenic older women. The main study hypothesis is that a program of resistance exercise will improve physical performance and functional status in sarcopenic older women compared against general recommendations.

This is a single-blind, controlled clinical trial, including women> 70 years, living in the community with sarcopenia. Those who agree to participate, will be randomly assigned to one of the following groups:

  1. Resistance Exercise Group

  2. General Recommendations Group (control) The study will last 24 weeks, with 4 measurements performed at baseline, week 6, 12 and 24. Multilevel models (random effects) will be constructed for the comparison between the two groups. Tests will be conducted with a P=0.05 and confidence intervals at 95%. This protocol has been approved by the local ethics committee.

Condition or Disease Intervention/Treatment Phase
  • Other: Resistance Exercise Group
N/A

Detailed Description

Study withdrawn.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Resistance Exercise Effect on Physical Performance and Functional Status in Sarcopenic Older Women
Actual Primary Completion Date :
Apr 1, 2013

Arms and Interventions

Arm Intervention/Treatment
No Intervention: General Recommendations Group

General information about sarcopenia will be provided to the participants, as well as general recommendations of healthy habits. We will contact the participants weekly by phone to answer questions about sarcopenia, and remind them of their next appointment and about adverse events occured during this period of time. The frequent contact with the participants has also the purpose to prevent losses or rejections for future evaluations

Experimental: Resistance Exercise Group

An individualized resistance exercise program wil be applied twice a week by an expert physiotherapist. Every 2 weeks, intensity will be reassessed by the same physiotherapist. Weekly, participants will be asked about incidents such as the occurrence of falls or hospitalizations during this study period. Physical performance and functional status will be assessed by the blind investigator at weeks 6,12 and 24

Other: Resistance Exercise Group
An individualized resistance exercise program wil be applied twice a week by an expert physiotherapist. Every 2 weeks, intensity will be reassessed by the same physiotherapist. Weekly, participants will be asked about incidents such as the occurrence of falls or hospitalizations during this study period. Physical performance and functional status will be assessed by the blind investigator at weeks 6,12 and 24

Outcome Measures

Primary Outcome Measures

  1. Improvement in gait speed and functional status in sarcopenic older women [improvement in gait speed and functional status in sarcopenic older women in weeks 6,12 and 24]

Secondary Outcome Measures

  1. Increase in muscle mass in sarcopenic older women [Increase in muscle mass in sarcopenic older women in week 24]

Eligibility Criteria

Criteria

Ages Eligible for Study:
70 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Body mass composition by BIA with skeletal muscle mass <6.76kg/m2

  • Speed gait of <0.8m/sec

  • Handgrip strength (adjusted for BMI) less than 20kg

Exclusion Criteria:
  • Current diagnosis of malnutrition (BMI <19kg/m2)

  • Decompensated heart failure (NYHA III or IV)

  • Hemiplegia or hemiparesis due to cerebral vascular disease

  • Exacerbation of chronic obstructive pulmonary disease

  • Dementia (any type, moderate or severe stage)

  • Uncontrolled diabetes mellitus (glycosylated hemoglobin >8%)

  • Severe pain in hips, knees or ankles

  • Fracture of lower limb in the last 6 months

  • Myocardial infarction within the past 6 months

  • Severe hypertension (SBP > 180mmHg or DBP > 110 mmHg)

  • Orthostatic hypotension

Contacts and Locations

Locations

Site City State Country Postal Code
1 National Institue of Medical Sciences and Nutrition Salvador Zubirán Mexico City Mexico 14000

Sponsors and Collaborators

  • National Institute of Medical Sciences and Nutrition, Salvador Zubiran

Investigators

  • Principal Investigator: JOSE ALBERTO AVILA FUNES, MD PhD, GERIATRICS CHIEF DEPARTMENT

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
José Alberto Ávila Funes, PhD, National Institute of Medical Sciences and Nutrition, Salvador Zubiran
ClinicalTrials.gov Identifier:
NCT01829009
Other Study ID Numbers:
  • GER-887-13/14-1
First Posted:
Apr 11, 2013
Last Update Posted:
Apr 22, 2015
Last Verified:
Apr 1, 2015
Keywords provided by José Alberto Ávila Funes, PhD, National Institute of Medical Sciences and Nutrition, Salvador Zubiran
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 22, 2015